Subtle issues in model specification and estimation of marginal structural models-Reference-Cited by-同舟云学术

Subtle issues in model specification and estimation of marginal structural models

Published:2012-01-16 Issue:3 Volume:21 Page:241-245
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Yang Wei¹,Joffe Marshall M.¹

Affiliation:

1. Department of Biostatistics and Epidemiology Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania School of Medicine; Philadelphia; PA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference12 articles.

1. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures;Brumback;Stat Med,2004

2. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure: a marginal structural model approach;Desai;Pharmacoepidemiol Drug Saf,2011

3. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease;Hernan;Epidemiology,2008

4. Causal inference with general treatment regimes: generalizing the propensity score;Imai;J Am Stat Assoc,2004

5. Model selection, confounder control, and marginal structural models: review and new applications;Joffe;American Statistician,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marshall Joffe's Contributions to Causal Inference, Biostatistics and Epidemiology;American Journal of Epidemiology;2023-11-07

2. Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips;Journal of Epidemiology;2020-09-05

3. Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study;Journal of the American Geriatrics Society;2017-09-21

4. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease;Journal of the American Geriatrics Society;2017-09-05

5. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection;Pharmacoepidemiology and Drug Safety;2017-07-19